46708 Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 

Contact Person listed below in advance 

of the meeting. The meeting will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov). 

Name of Committee: National Cancer 

Institute Clinical Trials and Translational 

Research Advisory Committee. 

Date: November 10, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: Strategic Discussion of NCI’s 

Clinical and Translational Research 

Programs. 

Place: National Cancer Institute, 9609 

Medical Center Drive, Rockville, MD 20850 

(Virtual Meeting). 

Contact Person: Sheila A. Prindiville, M.D., 

M.P.H., Director, Coordinating Center for 

Clinical Trials, National Cancer Institute, 

National Institutes of Health, 9609 Medical 

Center Drive, Room 6W136, Rockville, MD 

20850, 240–276–6173, prindivs@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/ctac/ctac.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 16, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17821 Filed 8–18–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the National Advisory 

Environmental Health Sciences Council, 

September 13, 2021, 11:00 a.m. to 

September 14, 2021, 04:45 p.m., 

National Institute of Environmental 

Health Science, Durham, NC 27709 

which was published in the Federal 

Register on August 16, 2021, FR Doc 

2021–17410, 86 FR 45742. 

This notice is being amended to 

change the meeting date from 

September 13–14, 2021 to September 

13, 2021. The start time for open session 

is also amended and will now start at 

11:45 a.m. and adjourn at 5:15 p.m. The 

meeting is partially closed to the public. 

Dated: August 16, 2021. 

David Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17819 Filed 8–18–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5: NCI 

Clinical and Translational Cancer Research. 

Date: October 6–7, 2021. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248, Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group; Career 

Development Study Section (J). 

Date: October 12–13, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W624, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Tushar Deb, Ph.D., 

Scientific Review Officer, Resources & 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850, 

240–276–6132, tushar.deb@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Strengthening Institutional Capacity to 

Conduct Global Cancer Research in Low- and 

Middle-Income Countries. 

Date: October 12, 2021. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248, Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Review of Informatics Technology in Cancer 

Research. 

Date: October 14–15, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W640, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Rockville, 

Maryland 20850, 240–276–7684, 

saejeong.kim@nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group; Institutional 

Training and Education Study Section (F). 

Date: October 18–19, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W234, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

7W234, Rockville, Maryland 20850, 240– 

276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Centers on 

Telehealth Research for Cancer-Related Care 

(P50 Clinical Trial Required). 

Date: October 20–21, 2021. 

Time: 9:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W108, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 


lotter on DSK11XQN23PROD with NOTICES1